Lupron Depot-ped 3 Month Generic Name & Formulations
Leuprolide acetate 11.25mg, 30mg; per kit; depot susp for IM inj; preservative-free.
Depot-PED kit—1 (prefilled dual-chamber syringe w. diluent, supplies); Depot-PED 3 Month kit—1 (prefilled dual-chamber syringe w. diluent, supplies)
Lupron Depot-ped 3 Month Indications
Central precocious puberty.
Lupron Depot-ped 3 Month Dosage and Administration
<1yr: not established. ≥1yrs: 11.25mg or 30mg as a single IM inj once every 3 months into the gluteal area, anterior thigh, or shoulder; rotate inj sites. If inadequate response, consider other alternative treatments.
Lupron Depot-ped 3 Month Contraindications
Lupron Depot-ped 3 Month Boxed Warnings
Lupron Depot-ped 3 Month Warnings/Precautions
Must be administered by a healthcare professional. Initial transient rise in gonadotropins and sex steroids may result in increased signs/symptoms of puberty. Monitor LH and sex steroid levels at 1–2 months after treatment initiation, with dose changes, and as clinically indicated; for Depot 3-Month: monitor at months 2–3, month 6 and as needed thereafter. Measure height and bone age velocity every 6–12 months. Monitor for pseudotumor cerebri or psychiatric symptoms. History of seizures/epilepsy, cerebrovascular disorders, CNS anomalies or tumors: risk of convulsions. Exclude pregnancy prior to initiation. Advise females of reproductive potential to use non-hormonal method of contraception during treatment. Nursing mothers.
Lupron Depot-ped 3 Month Pharmacokinetics
Lupron Depot-ped 3 Month Interactions
Caution with concomitant drugs that are associated with convulsions (eg, bupropion, SSRIs).
Lupron Depot-ped 3 Month Adverse Reactions
Transient exacerbation of symptoms, inj site reactions, pain, headache, emotional lability, acne/seborrhea, rash, vaginitis, vaginal discharge, syncope, GI upset, gynecomastia, weight increased, mood altered.
Lupron Depot-ped 3 Month Clinical Trials
Lupron Depot-ped 3 Month Note
Lupron Depot-ped 3 Month Patient Counseling